SCHEMBL25706306

SCHEMBL25706306

CNC1=C(NCc2ccccc2)C(=O)C(=O)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.51
▸ HKDC1 Q2TB90 3/20 0.51
▸ KDM4E B2RXH2 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ NSD2 O96028 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ GALK1 P51570 1/20 0.51
▸ BLM P54132 1/20 0.51
▸ PLEC Q15149 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ HTT P42858 2/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ APAF1 O14727 1/20 0.43
▸ HK1 P19367 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466820 0.73 NSD2 (0.71) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL29226600 0.73 RAB9A (0.58) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL11037676 0.70 MEN1 (0.55) RAB9AKDM4EMAPTLMNANPSR1
SCHEMBL17249922 0.70 HKDC1 (0.50) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL11334587 0.69 MEN1 (0.58) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL12333959 0.69 RAB9A (0.57) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL9750769 0.68 HKDC1 (0.60) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL10195778 0.68 MAPT (1.00) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL19956897 0.67 MAPKAPK2 (0.57) RAB9AHKDC1KDM4EMAPTLMNA
SCHEMBL2814457 0.67 MAOA (0.57) RAB9AHKDC1KDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180034-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING NAPHTHOQUINONE-BASED COMPOUND AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENTS NADIANBIO Ltd. (KR) 2023-05-17 — — EP disclosed
Send feedback